Overexpression of IGF-IR in malignant clonal cells in bone marrow of myelodysplastic syndromes

Cancer Investigation

Volumn 28, Issue 10, 2010, Pages 983-988

  He, Qi ^a   Li, Xiao ^a   Zhang, Zheng ^a   Zhang, Qianqiao ^a   Xu, Feng ^a   Yang, Lianping ^a   Tao, Ying ^a   Liu, Yizhi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Clone; IGF IR; Myelodysplastic syndromes

Indexed keywords

ALKALINE PHOSPHATASE; CELL MARKER; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL CLONE; CELL SURFACE; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOCYTOCHEMISTRY; KARYOTYPE; MALE; MULTINUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CLONE CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RECEPTOR, IGF TYPE 1; YOUNG ADULT;

EID: 78649314063     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.489537     Document Type: Article

References (16)

1. Grothey, A.; Voigt, W.; Schöber, C.; Müller, T.; Dempke, W.; Schmoll, H. J.. The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors. J Cancer Res Clin Oncol 1999, 125 (3-4), 166-173.
2. Raza, A.; Mundle, S.; Iftikhar, A.; Gregory, S.; Marcus, B.; Khan, Z.; Alvi, S.; Shetty, V.; Dameron, S.; Wright, V.. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 1995, 48, 143-154.
3. Qi, H.; Xiao, L.; Lingyun, W.; Ying, T.; Yi-Zhi, L.; Shao-Xu, Y.; Quan, P.. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis. Ann Hematol 2006, 85 (2), 95-101.
4. Multani, A. S.; Hopwood, V. L.; Pathak, S. A modified fluorescence in situ hybridization (FISH) technique. Anticancer Res 1996, 16, 3435-3437. (Pubitemid 27084994)
5. Baserga, R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 2000, 19 (49), 5574-5581.
6. Hankinson, S. E.; Willett, W. C.; Colditz, G. A.; Hunter, D. J.; Michaud, D. S.; Deroo, B.; Rosner, B.; Speizer, F. E.; Pollak, M.. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 1998, 351, 1393-1396. (Pubitemid 28209997)
7. Chan, J. M.; Stampfer, M. J.; Giovannucci, E.; Gann, P. H.; Ma, J.; Wilkinson, P.; Hennekens, C. H.; Pollak, M.. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998, 279, 563-566. (Pubitemid 28067285)
8. Yu, H.; Spitz, M. R.; Mistry, J.; Gu, J.; Hong, W. K.; Wu, X.. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control study. J Natl Cancer Inst 1999, 91, 151-156.
9. Whelan, J. T.; Ludwig, D. L.; Bertrand, F. E. HoxA9 induces insulinlike growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia. Leukemia 2008, 22 (6), 1161-1169.
10. Schillaci, R.; Galeano, A.; Becu-Villalobos, D.; Spinelli, O.; Sapia, S.; Bezares, R. F.. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia. Br J Haematol 2005, 130 (1), 58-66.
11. Tazzari, P. L.; Tabellini, G.; Bortul, R.; Papa, V.; Evangelisti, C.; Grafone, T.; Martinelli, G.; McCubrey, J. A.; Martelli, A. M.. The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. Leukemia 2007, 21 (5), 886-896.
12. Strömberg, T.; Ekman, S.; Girnita, L.; Dimberg, L. Y.; Larsson, O.; Axelson, M.; Lennartsson, J.; Hellman, U.; Carlson, K.; Osterborg, A.; Vanderkerken, K.; Nilsson, K.; Jernberg-Wiklund, H.. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Blood 2006, 107 (2), 669-678.
13. Ratajczak, J.; Zhang, Q.; Pertusini, E.; Wojczyk, B. S.; Wasik, M. A.; Ratajczak, M. Z.. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under-free conditions-comparison to other cytokines and growth factors. Leukemia 1998, 12 (3), 371-381.
14. Reiss, K.; Porcu, P.; Sell, C.; Pietrzkowski, Z.; Baserga, R.. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells. Oncogene 1992, 7 (11), 2243-2248.
15. Eshet, R.; Silbergeld, A.; Zaizov, R.; Stark, B.; Freud, E.; Laron, Z.; Shamai, Y.. Decreased insulin-like growth factor-I receptor sites on circulating mononuclear cells from children with acute leukemia. Pediatr Hematol Oncol 2000, 17 (3), 199-201.
16. Eivindson, M.; Grønbaek, H.; Skogstrand, K.; Thorsen, P.; Frystyk, J.; Flyvbjerg, A.; Dahlerup, J. F.. The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease. Scand J Gastroenterol 2007, 42 (4), 464-467.